Paraneoplastic and Cancer Treatment-Related Rheumatic Disorders, an Issue of Rheumatic Disease Clinics, Vol. 37-4

DESCRIPTION

This issue of Rheumatic Disease Clinics of North America provides foundational and in-depth information about paraneoplastic and cancer treatment-related rheumatic disorders, in which every practicing rheumatologist should be well-versed. Topics covered include neoplasm risk in patients with rheumatic diseases; neoplasm risk of anti-rheumatic therapy; rheumatologic laboratory findings in malignancy; rheumatic manifestations of primary and metastatic bone tumors and paraneoplastic bone disease; neoplastic/paraneoplastic synovitis; neoplastic/paraneoplastic dermatitis, fasciitis, and panniculitis; neoplastic/paraneoplastic vasculitis, vasculopathy, and hypercoagulability; neoplastic/paraneoplastic myalgias and myositis; and less-common neoplastic/paraneoplastic syndromes.

AUTHOR INFORMATION

By Kenneth J. Scalapino, MD, Section Chief, Rheumatology Hospital Road Portland, OR and Charles R Thomas JR, MD, Professor & Chairman Dept. of Radiation Medicine Portland, OR